Injectable retroviral particles for human gene therapy
- 5 December 1995
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 17 (3), 213-226
- https://doi.org/10.1016/0169-409x(95)00054-b
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Human gene therapy comes of ageNature, 1992
- Human gene therapyScience, 1992
- Direct Binding of Complement Component C1q to Human Immunodeficiency Virus (HIV) and Human T Lymphotrophic Virus-I (HTLV-I) Coinfected CellsAIDS Research and Human Retroviruses, 1991
- The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serumVirology, 1986
- Human T-cell leukaemia virus is not lysed by human serumNature, 1984
- Mechanism of antibody-independent activation of the first component of complement (C1) on retrovirus membranesBiochemistry, 1980
- Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.The Journal of Experimental Medicine, 1978
- Inactivation and lysis of oncornaviruses by human serumVirology, 1976
- Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.The Journal of Experimental Medicine, 1976
- Human serum lyses RNA tumour virusesNature, 1975